Abstract:Objective Efferocytosis dysfunction contributes to the progression and rupture of atherosclerotic plaques. Efferocytosis is crucially modulated by intracytoplasmic Ca 2+ , and mitochondrial calcium uniporter (MCU) complex proteins serve as key channels for regulating Ca 2+ concentration. Therefore, it was speculated that MCU may affect the development of atherosclerosis (AS) by regulating efferocytosis. In the present study, we aimed to investigate whether MCU could affect foam cell formation by regulating efferocytosis. Methods We stimulated primary macrophages (Møs) using oxidized low-density lipoprotein (ox-LDL) to mimic the atherosclerotic microenvironment and treated them with Ru360, an MCU-specific inhibitor, and UNC1062, an inhibitor of efferocytosis. Additionally, we conducted double staining to determine the Mø efferocytosis rate. We measured the expression of MCU complexes and efferocytosis-associated proteins using western blotting (WB) and real-time quantitative polymerase chain reaction (RT-qPCR), respectively. In addition, we separately detected the Ca 2+ level in the cytoplasm and mitochondria (MT) using Fluo-4 AM and Rhod-2 methods. We separately determined the reactive oxygen species (ROS) level in cytoplasm and MT using dichlorodihydrofluorescein diacetate (DCFH-DA) fluorescent probing method and Mito-SOXTM superoxide indicator staining. Additionally, we conducted the enzyme-linked immunosorbent assay (ELISA) to detect the production of interleukin-6 (IL-6), interleukin-18 (IL-18), interleukin-1β (IL-1β), and tumor necrosis factor-alpha (TNF-α). Oil Red O staining was performed to measure cytoplasmic lipid levels. Results Ru360 attenuated ox-LDL-induced efferocytosis dysfunction, and attenuated the upregulation of MCU and MCUR1 induced by ox-LDL, and meanwhile attenuated the downregulation of MCUb induced by ox-LDL. Ru360 attenuated the decrease of intracytoplasmic Ca 2+ concentration induced by ox- LDL, Ru360 also attenuated the ROS production induced by ox- LDL, attenuated the release of IL-6, IL-18, IL-1β, and TNF-α induced by ox- LDL, and attenuated the increase of intracytoplasmic lipid content induced by ox-LDL. UNC1062 attenuated the effects of Ru360 in reducing inflammatory cytokines and intracytoplasmic lipid content. Conclusions In this study, we found that MCU inhibition modulated intracytoplasmic Ca 2+ concentration, improved impaired Mø efferocytosis, and reduced ROS generation. Macrophage efferocytosis removed apoptotic cells and prevented the release of inflammatory factor and foam cell formation, and this can be a potential new therapeutic target for alleviating atherosclerosis.

Alteration of Volume-Regulated Chloride Channel During Macrophage-Derived Foam Cell Formation in Atherosclerosis.

Intracellular-free calcium dynamics and F-actin alteration in the formation of macrophage foam cells.

Reduction of Intracellular Chloride Concentration Promotes Foam Cell Formation

Research Progress on Biological Characteristics and Function of Volume Regulated Cl-Channel in Vascular Smooth Muscle Cells

[Inhibition of Human Macrophage-Derived Foam Cell Differentiation by Blocking Kv1.3 and Kir2.1 Channels].

Modulation of Oxidized Low-density Lipoprotein-Affected Macrophage Efferocytosis by Mitochondrial Calcium Uniporter in a Murine Model

Role of Rab5 in the Formation of Macrophage-Derived Foam Cell.

Autophagy Is Differentially Regulated in Leukocyte and Nonleukocyte Foam Cells During Atherosclerosis

LRPPRC Inhibits Autophagy and Promotes Foam Cell Formation in Atherosclerosis

Oxldl/β2gpi/anti-Β2gpi Complex Induced Macrophage Differentiation to Foam Cell Involving TLR4/NF-kappa B Signal Transduction Pathway

Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development.

Lipid Homeostasis and the Formation of Macrophage-Derived Foam Cells in Atherosclerosis

Macrophage KLF15 prevents foam cell formation and atherosclerosis via transcriptional suppression of OLR-1

SCD1 activation impedes foam cell formation by inducing lipophagy in oxLDL-treated human vascular smooth muscle cells.

Macrophage-derived Foam Cells Impair Endothelial Barrier Function by Inducing Endothelial-Mesenchymal Transition Via CCL-4.

Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation

Inhibitory Effects of Blocking Voltage-Dependent Potassium Channel 1.3 on Human Monocyte-Derived Macrophage Differentiation into Foam Cells

Abstract 5523: High Glucose Promotes Intracellular Lipid Accumulation by Impairing the Balance Between CD36 and ATP-Binding Cassette Transporter G1 in Vascular Smooth Muscle Cells

Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Atherosclerosis by Affecting Foam Cell Formation and Efferocytosis.

Receptor-independent fluid-phase macropinocytosis promotes arterial foam cell formation and atherosclerosis

Tenascin-C produced by oxidized LDL-stimulated macrophages increases foam cell formation through toll-like receptor-4